4 views left Get unlimited views with a free account

Explore the latest trends and actionable insights on the Uveal Melanoma Pipeline Drugs to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Uveal Melanoma by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 63 ongoing clinical trials involving Uveal Melanoma
Of the 63 trials,20 trials are in Phase II
Furthermore, 18 trials are in Phase I/II

Number of ongoing Clinical Trials (for drugs) involving Uveal Melanoma by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Uveal Melanoma, an Oncology condition. The largest number of ongoing clinical trials for Uveal Melanoma is conducted in North America. Europe and Asia-Pacific are among some of the other prominent regions engaged in Uveal Melanoma-related drug trials.

University of Texas MD Anderson Cancer Center: The leading ongoing Uveal Melanoma related clinical trial sponsor

University of Texas MD Anderson Cancer Center is the top sponsor for Uveal Melanoma-related ongoing clinical trials.

Herbert Irving Comprehensive Cancer Center, Thomas Jefferson University Hospitals, Columbia University and University of Virginia are among other notable clinical trial sponsors involved in Uveal Melanoma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.

Explore the latest trends and actionable insights on the Uveal Melanoma Pipeline Drugs to inform business strategy and pinpoint opportunities and risks. Explore the latest trends and actionable insights on the Uveal Melanoma Pipeline Drugs to inform business strategy and pinpoint opportunities and risks. Visit Report Store